Tips and Insights
Here are some tips & insights extracted from C.E.L.forpharma’s courses. Some are plain definitions of terms that often cause confusion, others offer invaluable advice for better planning and decision-making. Use the filters to find insights related to your functional area.
10 Critical success factors for pharma lifecycle management
| Expert: | Dr. Neal Hansen |
| Course: | Late Stage Pharma Lifecycle Management |
13 Checkpoints to critically assess the quality of your brand marketing plans
| Expert: | Edouard Demeire |
| Course: | The Pharma Brand Planning Course |
3 main problem areas in pharma business development
| Expert: | Martin Austin |
| Course: | The Pharma Business Development Course |
9,5 steps to a successful Advisory Board Meeting – Do you actually need one?
| Expert: | Maaike Addicks, MD |
| Course: | The Value Adding Medical Science Liaison |
A 5-step process for planning late stage lifecycle management
| Expert: | Dr. Neal Hansen |
| Course: | Late Stage Pharma Lifecycle Management |
An often overlooked element in the process of designing Patient Support Programmes
| Expert: | Prof. John Weinman & Nathan O’Donnell |
| Course: | Principles of Patient Adherence & Support Solutions |
Are you up to date on the use of internet by European physicians?
| Expert: | Vladimir Rogiers |
| Course: | The Strategic Digital Pharma Marketing Course |
Choose the right generic strategy for your mature brands!
| Expert: | Dr. Neal Hansen |
| Course: | Late Stage Pharma Lifecycle Management |
Commonly misused pricing terms in pharma – (1)
| Expert: | Gary Johnson |
| Course: | Value Pricing for Market Access |
Commonly misused pricing terms in pharma – (2)
| Expert: | Gary Johnson |
| Course: | Value Pricing for Market Access |
Core MSL competencies – A training priority!
| Expert: | Maaike Addicks, MD |
| Course: | The Value Adding Medical Science Liaison |
Creating the right environment for your MSLs
| Expert: | Maaike Addicks, MD |
| Course: | The Value Adding Medical Science Liaison |
Do you have an effective market access planning process in place for new brands?
| Expert: | Mark Silvey & Dr. Nick Proctor |
| Course: | Principles of Pharma Market Access in Europe |
Do you know the 5 categories of payers and their respective roles and drivers?
| Expert: | Mark Silvey & Dr. Nick Proctor |
| Course: | Principles of Pharma Market Access in Europe |
Do you know the answer to this exercise on QALYs?
| Expert: | Prof. Dr. Lieven Annemans |
| Course: | Health Economics for Non-Health-Economists |
Do you know the key determinants of parallel trade?
| Expert: | Gary Johnson |
| Course: | Value Pricing for Market Access |
Do you know the key drivers of price sensitivity for pharmaceuticals?
| Expert: | Gary Johnson |
| Course: | Value Pricing for Market Access |